Human VANGL2/LPP1/LTAP ORF/cDNA clone-Lentivirus particle (NM_020335)
Cat. No.: vGMLP001083
Pre-made Human VANGL2/LPP1/LTAP Lentiviral expression plasmid for VANGL2 lentivirus packaging, VANGL2 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
The GM Vector Core (GMVC) specializes in custom lentivirus development and offers a range of lentivirus manufacturing solutions, leveraging state-of-the-art processes. Learn more about our services.
Go to
VANGL2/LPP1 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Catalog No. | Product Name | lentivirus Grade | lentivirus quantity |
---|---|---|---|
vGMLP001083 | Human VANGL2 Lentivirus particle | Pilot Grade | 1.0E+8TU |
5.0E+8TU | |||
1.0E+9TU | |||
Research Grade | 1.0E+8TU | ||
5.0E+8TU | |||
1.0E+9TU | |||
GMP-like Grade | inquiry | ||
GMP Grade | inquiry |
Product Description
Catalog ID | vGMLP001083 |
Gene Name | VANGL2 |
Accession Number | NM_020335 |
Gene ID | 57216 |
Species | Human |
Product Type | Lentivirus particle (overexpression) |
Insert Length | 1566 bp |
Gene Alias | LPP1,LTAP,STB1,STBM,STBM1 |
Fluorescent Reporter | ZsGreen |
Mammalian Cell Selection | Puromyocin |
Fusion Tag | 3xflag (C-Terminal) |
Promoter | CMV |
Resistance | Amplicin |
ORF Nucleotide Sequence | ATGGACACCGAGTCCCAGTACTCGGGCTATTCCTACAAGTCGGGCCACTCCCGCAGCTCCCGCAAGCACAGGGACCGCCGGGACCGACACCGCTCTAAGAGTCGAGATGGGGGCCGAGGGGACAAGTCGGTGACAATCCAGGCTCCCGGGGAGCCCCTGCTGGACAATGAGTCCACACGAGGGGATGAGCGGGATGACAACTGGGGGGAAACGACGACAGTAGTAACGGGCACCTCAGAGCACAGCATCTCCCATGATGACCTCACACGCATCGCCAAGGACATGGAGGACAGTGTCCCTCTGGACTGCTCCCGTCACCTGGGTGTGGCAGCGGGGGCCACCCTGGCACTGCTGTCTTTCCTCACGCCTCTGGCCTTCCTGCTGCTGCCCCCACTGCTGTGGCGGGAGGAGCTGGAGCCTTGCGGGACGGCCTGCGAGGGCCTCTTCATCTCTGTCGCCTTCAAGCTGCTCATCCTGCTACTGGGCAGCTGGGCTCTGTTCTTCCGCCGGCCCAAGGCCTCGCTGCCCCGCGTCTTTGTGCTGCGTGCCCTGCTTATGGTGCTGGTTTTCCTGCTCGTGGTCTCCTACTGGCTCTTCTATGGTGTGCGCATCCTGGATGCTCGGGAGCGCAGCTACCAGGGCGTGGTGCAGTTCGCCGTGTCGCTGGTGGACGCCCTTCTTTTCGTGCACTACCTGGCCGTGGTCCTGCTGGAGCTGCGCCAGCTCCAGCCTCAGTTCACGCTCAAGGTCGTGCGCTCCACCGACGGCGCCAGCCGCTTCTACAACGTTGGCCATCTCAGCATCCAGCGCGTGGCAGTGTGGATCCTGGAGAAGTATTACCATGACTTCCCTGTCTACAACCCTGCCCTCCTCAACCTGCCCAAGTCCGTCCTGGCCAAGAAAGTGTCTGGCTTCAAGGTGTATTCCCTCGGAGAGGAAAACAGCACCAACAACTCCACTGGCCAGTCTCGGGCTGTGATTGCAGCGGCAGCTCGGAGGCGGGACAACAGTCACAATGAGTACTACTATGAGGAGGCTGAGCATGAGCGAAGGGTGCGCAAGAGGAGGGCCAGGCTTGTAGTGGCGGTGGAGGAGGCCTTCACTCACATTAAGCGGCTGCAGGAAGAGGAGCAGAAAAACCCCAGGGAGGTGATGGACCCCCGGGAGGCAGCCCAAGCCATCTTTGCATCCATGGCCCGTGCCATGCAGAAGTACCTTCGGACCACCAAGCAGCAGCCCTACCACACCATGGAGAGCATCCTGCAGCACCTTGAATTCTGCATCACGCATGACATGACGCCCAAGGCCTTCTTGGAGCGATACTTGGCGGCTGGACCTACCATCCAGTACCACAAGGAACGCTGGCTGGCCAAACAGTGGACATTGGTGAGCGAGGAGCCGGTGACCAACGGCCTCAAGGATGGCATCGTTTTCCTCTTAAAACGCCAGGACTTCAGCCTGGTGGTCAGCACCAAGAAGGTCCCATTCTTCAAACTCTCCGAGGAATTTGTGGATCCCAAGTCACACAAGTTTGTCATGAGGCTGCAGTCTGAGACCTCAGTGTGA |
ORF Protein Sequence | MDTESQYSGYSYKSGHSRSSRKHRDRRDRHRSKSRDGGRGDKSVTIQAPGEPLLDNESTRGDERDDNWGETTTVVTGTSEHSISHDDLTRIAKDMEDSVPLDCSRHLGVAAGATLALLSFLTPLAFLLLPPLLWREELEPCGTACEGLFISVAFKLLILLLGSWALFFRRPKASLPRVFVLRALLMVLVFLLVVSYWLFYGVRILDARERSYQGVVQFAVSLVDALLFVHYLAVVLLELRQLQPQFTLKVVRSTDGASRFYNVGHLSIQRVAVWILEKYYHDFPVYNPALLNLPKSVLAKKVSGFKVYSLGEENSTNNSTGQSRAVIAAAARRRDNSHNEYYYEEAEHERRVRKRRARLVVAVEEAFTHIKRLQEEEQKNPREVMDPREAAQAIFASMARAMQKYLRTTKQQPYHTMESILQHLEFCITHDMTPKAFLERYLAAGPTIQYHKERWLAKQWTLVSEEPVTNGLKDGIVFLLKRQDFSLVVSTKKVPFFKLSEEFVDPKSHKFVMRLQSETSV |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
---|---|---|
Target Antibody | GM-Tg-g-MP1916-Ab | Anti-VANG2/ VANGL2/ LPP1 monoclonal antibody |
Target Antigen | GM-Tg-g-MP1916-Ag | VANGL2 VLP (virus-like particle) |
ORF Viral Vector | pGMLP001083 | Human VANGL2 Lentivirus plasmid |
ORF Viral Vector | pGMLV000539 | Human VANGL2 Lentivirus plasmid |
ORF Viral Vector | pGMLV002352 | Human VANGL2 Lentivirus plasmid |
ORF Viral Vector | vGMLP001083 | Human VANGL2 Lentivirus particle |
ORF Viral Vector | vGMLV000539 | Human VANGL2 Lentivirus particle |
ORF Viral Vector | vGMLV002352 | Human VANGL2 Lentivirus particle |
Target information
Target ID | GM-MP1916 |
Target Name | VANGL2 |
Gene ID | 57216, 93840, 720239, 289229, 101094645, 610037, 520544, 100053765 |
Gene Symbol and Synonyms |
C530001F03Rik,loop-tail,Lootl,Lp,LPP1,LTAP,ska17,ska |
Uniprot Accession | Q9ULK5 |
Uniprot Entry Name | VANG2_HUMAN |
Protein Sub-location | Transmembrane Protein |
Category | Not Available |
Disease | Not Available |
Gene Ensembl | ENSG00000162738 |
Target Classification | Not Available |
The protein encoded by this gene is a membrane protein involved in the regulation of planar cell polarity, especially in the stereociliary bundles of the cochlea. The encoded protein transmits directional signals to individual cells or groups of cells in epithelial sheets. This protein is also involved in the development of the neural plate. [provided by RefSeq, Sep 2011]
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.